ACOG Guideline Addresses Hepatitis in Pregnancy
TUESDAY, Aug. 22, 2023 -- In a clinical practice guideline issued by the American College of Obstetricians and Gynecologists and published online Aug. 17 in Obstetrics& Gynecology, recommendations are presented for hepatitis B and C virus... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 22, 2023 Category: Pharmaceuticals Source Type: news
A Machine Learning Model for Predicting HCC Risk in Chronic HBV A Machine Learning Model for Predicting HCC Risk in Chronic HBV
The authors developed a machine learning algorithm to increase the accuracy of HCC prediction in patients with chronic hepatitis B receiving antiviral therapy.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 18, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Hepatitis medicines are cheaper now. Treat to save lives.
8 August 2023 – World Hepatitis Day is observed each year on 28 July. The slogan of this year’s regional campaign was “Hepatitis medicines are cheaper now. Treat to save lives”.
In WHO’s Eastern Mediterranean Region, countries/territories have been making slow progress towards testing and treatment targets to eliminate hepatitis as a public health problem by 2030. In 2021, 18 million people were estimated to be living with chronic hepatitis B, 14% of whom were diagnosed and 2% received treatment. In the same year, 12 million people were estimated to be living with chronic hepatitis C, of whom 37% were...
Source: WHO EMRO News - August 8, 2023 Category: Middle East Health Source Type: news
Nigeria: Viral Hepatitis - Nigeria Unlikely to Achieve Net Testing By 2030 - World Hepatitis Alliance
[Vanguard] The World Hepatitis Alliance, WHA, has said Nigeria is unlikely to achieve net testing of 90% of her population for Hepatitis B and C before the 2030 benchmark set by the deed of the Global Health Sector Strategy, GHSS, which the country is a part of. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 30, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
Angola: Angola Has More Than 30 Hepatitis B Treatment Units
[ANGOP] Luanda -- Thirty-five reference units for the treatment and monitoring of hepatitis B have been created since 2019 in Angola, the Secretary of State for Public Health, Pinto de Sousa, said Friday in Luanda. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 29, 2023 Category: African Health Tags: Angola Central Africa Health and Medicine Southern Africa Source Type: news
Nigeria: World Hepatitis Day 2023 - Despite Vaccine Availability, Disease Remains Threat in Nigeria
[Premium Times] Of the five strains of hepatitis, B and C have been described as global public health threats and the world's most common causes of liver infection. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
Ghana: Efforts to Prevent Childhood Hepatitis B Laudable
[Ghanaian Times] The Ghana Health Service (GHS) has announced its intention to introduce a vaccine for Hepatitis B virus (HBV) to be administered to babies at birth. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2023 Category: African Health Tags: Ghana Health and Medicine West Africa Source Type: news
Ghana: Childhood Immunisation Programme - Newborns to Receive Hepatitis B Vaccines ...Within 24hrs of Birth Beginning Next Year
[Ghanaian Times] Ghana will from next year introduce a vaccine for Hepatitis B virus (HBV) to be administered to babies at birth, the Director-General (D-G) of the Ghana Health Service (GHS), Dr Patrick Kuma-Aboagye, has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2023 Category: African Health Tags: Ghana Health and Medicine West Africa Source Type: news
The Head of the Global Vaccine Group Gavi Is Resigning. Here ’s What He Learned During the Pandemic
The COVID-19 pandemic was a crucible for the public health world, and perhaps none were tested more than Gavi, the global nonprofit that makes vaccines its business. Faced with ensuring that the COVID-19 vaccines reached as many people in the developing world as possible, the organization created a new entity, COVAX, that served as the conduit for purchasing and distributing vaccines for the lowest-resource countries in the world.
Dr. Seth Berkley, who has headed the organization for years, is stepping down in August when his current term ends.
In a conversation with TIME, Berkley reflects on his tenure and what he, Gavi, ...
Source: TIME: Health - July 24, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The Head of the Global Vaccine Group Gavi Is Stepping Down. Here ’s What He Learned During the Pandemic
The COVID-19 pandemic was a crucible for the public health world, and perhaps none were tested more than Gavi, the global nonprofit that makes vaccines its business. Faced with ensuring that the COVID-19 vaccines reached as many people in the developing world as possible, the organization created a new entity, COVAX, that served as the conduit for purchasing and distributing vaccines for the lowest-resource countries in the world.
Dr. Seth Berkley, who has headed the organization for years, is stepping down in August when his current term ends.
In a conversation with TIME, Berkley reflects on his tenure and what he, Gavi, ...
Source: TIME: Health - July 24, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Is a ‘polyepidemic’ humanity’s next big threat? Childhood vaccine crusader shares concerns for future
By the start of 2011, the year epidemiologist Seth Berkley became CEO of Gavi, the Vaccine Alliance, the ambitious nonprofit had over its 11-year history supported the immunization of 288 million children in poor countries. But it also had a $3.7 billion funding gap between its plans and donor financial pledges. Making matters worse, an internal battle raged about how much it should invest in strengthening health systems versus more technological solutions, such as new or improved vaccines, favored by its main funder, the Bill & Melinda Gates Foundation. “It was a crisis,” Berkley says.
Berkley plans to step ...
Source: ScienceNOW - July 20, 2023 Category: Science Source Type: news
Velia Therapeutics Announces Appointment of Veteran Drug Developer, John McHutchison, AO, MD as President and Chief Executive Officer
Dr. McHutchison is a world-renowned physician, scientist, and drug developer who has led the research and development of numerous marketed therapies for chronic hepatitis B (HBV), chronic hepatitis C (HCV) and multiple other serious diseases.
Dr. McHutc... Biopharmaceuticals, Personnel Velia Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2023 Category: Pharmaceuticals Source Type: news
Hepatitis B Vaccination Rates Lag in Patients With Psoriasis Hepatitis B Vaccination Rates Lag in Patients With Psoriasis
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 27, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV
(MedPage Today) -- VIENNA -- Tenofovir alafenamide (TAF; Biktarvy) continued to be highly effective for chronic hepatitis B virus (HBV) infection for up to 8 years, according to an analysis of long-term data.
Over this time period, viral suppression... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 26, 2023 Category: Gastroenterology Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
